Table 1

Characteristics of 53 patients with RA whose disease flared after discontinuation of second line treatment while being in remission

Age (years)* 59.9 (11.4)
Female (%)60
Duration of RA (years)* 10.6 (9)
ELISA IgM-RF positive (%)77
Erosive changes on x ray (%)75
Weeks between entry in the placebo controlled study and flare 27 (3 to 52)
Number of patients with severe flare24
  • Data shown as mean (SD)* and median (range).